Temperatures have been as much as 11C above normal in some regions...
Category:
Health
Latest
India needs regulatory data protection to attract drug research: Novartis CEO
, Vasant Narasimhan,Chief Executive Officer,Novartis ''I think the...
Nearly 30% of 2.2 billion people living with blindness globally are in the WHO South-East Asia Region
Trachoma is a disease of the eye caused by infection with the...
India’s coronavirus infections surge to 6.23 million
BENGALURU India’s coronavirus case tally surged to 6.23 million after it reported 80,472 new infections in the last 24 hours, data from the health ministry showed on Wednesday. Deaths from coronavirus infections rose by 1,179 in the last 24 hours to...
‘Take home’ lawsuits over COVID infections could be costly for U.S. employers
Between 7% and 9% of the roughly 200,000 U.S. COVID-19 deaths so far are believed to stem from take-home infections and the lawsuits could cost businesses up to $21 billion if the number of Americans fatalities reaches 300,000, according to Praedicat, a firm that evaluates risks for insurers.
Most executives seek work-life balance after experiencing pandemic blues – survey
Many top company officials in France and Egypt were most likely to have recalibrated their lives after experiencing the pandemic blues, followed by those in the United Arab Emirates, the United States and Britain, according to a survey of about 2,000 high net-worth individuals by health insurer Bupa Global.
Poorer countries to get 120 million $5 coronavirus tests, WHO says
WHO Director General Tedros Adhanom Ghebreyesus said the manufacturers Abbott and SD Biosensor had agreed with the Bill & Melinda Gates Foundation to “make 120 million of these new, highly portable and easy-to-use rapid COVID-19 diagnostic tests available over a period of six months”.
“This will enable the expansion of testing, particularly in hard-to-reach areas that do not have laboratory facilities or enough trained health workers to carry out tests,” Tedros said.
Health ministry launches web portal for updates on COVID-19 vaccine development
“The data will serve as an invaluable tool for formulating appropriate patient management strategies, predicting disease severity, patient outcomes etc,” the ICMR said in a statement.
Union Health Minister Harsh Vardhan, said, “The portal provides useful and important information related to vaccine development, ongoing clinical trials and progress made in this area locally and globally at regular intervals. Today, in the times of coronavirus pandemic, vaccine development is watched very closely. Thus, it becomes important to showcase the status of vaccine development in the country.”
COVID tally crosses 60 lakh; 1,039 more deaths
The total coronavirus cases mounted to 60,74,702, while 50,16,520 people have recuperated from the virus, taking the recovery rate to 82.58 per cent. The case fatality rate declined to 1.57 per cent, it said.
Travellers from Dubai, UK mainly behind Covid importation into India: Study
The study has also found that infected cases from Tamil Nadu, Delhi and Andhra Pradesh played less role in spreading the disease outside their communities. Whereas infected people in Gujarat, Rajasthan, Maharashtra, Kerala, Jammu and Kashmir, and Karnataka played a significant role in the local transmission, and some of them caused interstate transfer too.
Antibodies from recovered cases, antivirals may be bridge to Covid vaccine
With no vaccines yet proven to prevent Covid-19, health authorities must continue to push for new treatments and measures to stop the coronavirus from spreading, said Robert “Chip” Schooley, a professor of medicine at the University of California, San Diego, who is studying more potent versions of an existing antiviral.
Lloyd’s of London alerts India Inc on rising “Intangible Risks”, launches new solutions for Pandemic Risks
Specific to SMEs, Lloyd’s has developed ReStart, a potential non-damage business interruption solution (loss of revenue without a physical damage trigger) for future waves of COVID-19. The solution is focused on giving certainty of non-damage business interruption coverage initially to SMEs by pooling limited capacity across a number of Lloyd’s market participants. The product will support reopening of SMEs, offering a range of limits that ensure it is affordable for customers, without requiring any government support,
Lloyd’s is also working on a proposed ‘after the event’ insurance product framework, Recover Re, which would provide immediate relief and cover for non-damage business interruption, including the current COVID-19 pandemic, over the long-term. This framework could be implemented in any country where the government has the resources and industry commitment to support it.
India registers 85,362 new COVID-19 infections in a day; single-day recoveries surpass fresh cases
Total recoveries surged to 48,49,584, pushing the country’s recovery rate to 82.14 per cent. The COVID-19 case fatality rate was recorded at 1.58 per cent.
There are 9,60,969 active cases in the country which comprise 16.28 per cent of the total caseload, the data showed.